Markets›Health care›ABBV

AbbVie

ABBV
264.34
-0.78 (-0.29%)
Closing price for Sep 25, 2026 from Polygon.io

Valuation

Market value467.12B
Enterprise value523.03B
Price to earnings (P/E)74.7
Price to sales7.3
Enterprise value to EBITDA29.6
Free cash flow yield3.9%

Profitability (last 12 months)

Revenue64.39B
Net income6.31B
Gross margin71.5%
Operating margin26.2%
Net margin9.8%
Return on assets4.7%

Growth (last fiscal year, FY 2025)

Revenue growth+8.6%
EPS growth-1.3%

Balance sheet (latest quarter)

Cash and equivalents6.57B
Total debt62.48B
Current ratio0.81

Per share and dividends

EPS, diluted (last 12 months)3.54
Shares outstanding1.77B
Dividends paid (last 12 months)None

Trading

Price264.34
52-week high269.39
52-week low190.75
1-year price change+18.45%
Average volume (3 months)5.15M
Beta against the S&P 500 (1 year)-0.11

Calculated from AbbVie's SEC filings (latest quarter ending Jun 30, 2026) and the price above. "Last 12 months" adds up the four most recent quarters. Beta compares one year of daily returns with the S&P 500 (SPY). Dividends from Polygon.io or Nasdaq.